Cathy Graham

481 total citations
22 papers, 390 citations indexed

About

Cathy Graham is a scholar working on Cancer Research, Organic Chemistry and Pharmacology. According to data from OpenAlex, Cathy Graham has authored 22 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 7 papers in Organic Chemistry and 7 papers in Pharmacology. Recurrent topics in Cathy Graham's work include Microbial Natural Products and Biosynthesis (7 papers), Breast Cancer Treatment Studies (7 papers) and Bioactive Compounds and Antitumor Agents (4 papers). Cathy Graham is often cited by papers focused on Microbial Natural Products and Biosynthesis (7 papers), Breast Cancer Treatment Studies (7 papers) and Bioactive Compounds and Antitumor Agents (4 papers). Cathy Graham collaborates with scholars based in United States, Canada and South Africa. Cathy Graham's co-authors include David L. Jakeman, Ray T. Syvitski, Jason Wentzell, L. C. Vining, Wendy B. Young, Susan E. Douglas, B Srinivasulu, Jonathan Blay, Sherri A. McFarland and Steven R. Hall and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Chemical Communications.

In The Last Decade

Cathy Graham

19 papers receiving 380 citations

Peers

Cathy Graham
Andrew J. Robles United States
J. J. Catino United States
Lily L. Remsing United States
Jaechul Shim United States
Cathy Graham
Citations per year, relative to Cathy Graham Cathy Graham (= 1×) peers Nuria Menéndez

Countries citing papers authored by Cathy Graham

Since Specialization
Citations

This map shows the geographic impact of Cathy Graham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cathy Graham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cathy Graham more than expected).

Fields of papers citing papers by Cathy Graham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cathy Graham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cathy Graham. The network helps show where Cathy Graham may publish in the future.

Co-authorship network of co-authors of Cathy Graham

This figure shows the co-authorship network connecting the top 25 collaborators of Cathy Graham. A scholar is included among the top collaborators of Cathy Graham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cathy Graham. Cathy Graham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Shaughnessy, Joyce, Lajos Pusztai, Cathy Graham, et al.. (2024). Abstract PO5-15-04: MammaPrint index predicts neoadjuvant chemosensitivity in patients with HR+HER2- early-stage breast cancer in the real-world evidence FLEX study. Cancer Research. 84(9_Supplement). PO5–15.
2.
Lawal, Ismaheel O., Manali Bhave, Jane Meisel, et al.. (2024). Prospective investigation of amino acid transport and PSMA-targeted positron emission tomography for metastatic lobular breast carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 51(13). 4073–4082. 2 indexed citations
3.
Cobain, Erin F., Lajos Pusztai, Cathy Graham, et al.. (2024). Elucidating the immune active state of HR+HER2- MammaPrint High 2 early breast cancer.. Journal of Clinical Oncology. 42(16_suppl). 506–506. 3 indexed citations
4.
O’Shaughnessy, Joyce, Cathy Graham, Peter D. Beitsch, et al.. (2024). Association of MammaPrint index and 3-year outcome of patients with HR+HER2- early-stage breast cancer treated with chemotherapy with or without anthracycline.. Journal of Clinical Oncology. 42(16_suppl). 511–511. 3 indexed citations
5.
Lawal, Ismaheel O., Manali Bhave, Jane Meisel, et al.. (2023). A Discordant Pattern of Uptake on 68Ga-PSMA PET/CT Versus 18F-Fluciclovine PET/CT in Radiation-Induced Hepatitis. Clinical Nuclear Medicine. 48(4). e202–e203. 4 indexed citations
6.
Lawal, Ismaheel O., Sarah Friend, Jane Meisel, et al.. (2022). A Tale of 3 Tracers. Clinical Nuclear Medicine. 48(1). e26–e27. 2 indexed citations
7.
Graham, Cathy, Douglas K. Marks, Sami Diab, et al.. (2021). Whole transcriptome analysis comparing HR+ HER2- breast cancer tumors from patients < 50 years and >50 years.. Journal of Clinical Oncology. 39(15_suppl). 565–565.
8.
Kaklamani, Virginia, Cathy Graham, Karen L. Tedesco, et al.. (2020). Basal subtype and clinical estrogen receptor status of genomically basal breast tumors in Caucasian, African American, and Latin American patients.. Journal of Clinical Oncology. 38(15_suppl). 556–556.
9.
Whitworth, Pat W., et al.. (2019). Minimally Invasive Intact Excision of High-Risk Breast Lesions and Small Breast Cancers: The Intact Percutaneous Excision (IPEX) Registry. Annals of Surgical Oncology. 26(4). 954–960. 1 indexed citations
11.
Issa, Mark E., et al.. (2013). Jadomycins are cytotoxic to ABCB1-, ABCC1-, and ABCG2-overexpressing MCF7 breast cancer cells. Anti-Cancer Drugs. 25(3). 255–269. 30 indexed citations
12.
Monro, Susan, et al.. (2011). Copper-mediated nuclease activity of jadomycin B. Bioorganic & Medicinal Chemistry. 19(11). 3357–3360. 20 indexed citations
13.
Jakeman, David L., et al.. (2009). Isolation and characterization of jadomycin L from Streptomyces venezuelae ISP5230 for solid tumor efficacy studies. Pure and Applied Chemistry. 81(6). 1041–1049. 17 indexed citations
14.
Jakeman, David L., et al.. (2008). Antimicrobial Activities of Jadomycin B and Structurally Related Analogues. Antimicrobial Agents and Chemotherapy. 53(3). 1245–1247. 66 indexed citations
15.
Graham, Cathy, et al.. (2007). Stereochemical Integrity of Oxazolone Ring‐Containing Jadomycins. ChemBioChem. 8(10). 1198–1203. 41 indexed citations
16.
Jakeman, David L., Cathy Graham, Wendy B. Young, & L. C. Vining. (2006). Culture conditions improving the production of jadomycin B. Journal of Industrial Microbiology & Biotechnology. 33(9). 767–772. 58 indexed citations
17.
Jakeman, David L., et al.. (2006). Substrate flexibility of a 2,6-dideoxyglycosyltransferase. Chemical Communications. 3738–3738. 29 indexed citations
18.
Syvitski, Ray T., et al.. (2006). Ring-Opening Dynamics of Jadomycin A and B and Dalomycin T. Organic Letters. 8(4). 697–700. 32 indexed citations
19.
Jakeman, David L., et al.. (2005). Novel and expanded jadomycins incorporating non-proteogenic amino acids. Bioorganic & Medicinal Chemistry Letters. 15(23). 5280–5283. 22 indexed citations
20.
Chait, Laurence A., et al.. (2002). Modifying the Two-Stage Cleft Palate Surgical Correction. The Cleft Palate-Craniofacial Journal. 39(2). 226–232. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026